A Safety and Efficacy Study of Vitreosolve® for Non-Proliferative Diabetic Retinopathy Subjects

Inclusion Criteria: * Subjects with a history of systemic diabetes (type I or II) * Subject with a documented history of Non Proliferative Diabetic Retinopathy (NPDR) * Subjects with no PVD at baseline exam in the study eye. Exclusion Criteria: * Subjects with Retinal pathology in the study eye other than (NPDR) * Subjects with high myopia in the study eye * Subjects who have monocular vision or contra lateral vision of 20/200 or worse BCVA in the non-study eye. * Subjects with an aphakic study eye or if pseudophakic, cataract extraction surgery less than 6 months prior to study enrollment * Subjects that have had either vitrectomy surgery, intravitreal injections, or laser treatments in the study eye.